ITI Pharma and Healthcare Fund - Regular Plan - Growth Option
Category: Equity: Sectoral-Pharma and Healthcare
Launch Date: 08-11-2021
AUM:
₹ 214 Cr
Expense Ratio
2.35%
Benchmark
NIFTY Healthcare TRI.
ISIN
INF00XX01BL5
Minimum Investment
5000.0
Minimum Topup
1000.0
Minimum SIP Amount
500
Fund Manager
Dhimant Shah, Rohan Korde, Rajesh Bhatia
| Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
|---|---|---|---|
| ITI Pharma and Healthcare Fund - Regular Plan - Growth Option | 16.5 | 18.68 | - |
| NIFTY Healthcare TRI | 18.03 | 19.44 | 21.13 |
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
Overview
NAV
15.8703
Last change
0.01 (0.0466%)
Fund Size (AUM)
₹ 214 Cr
Performance
14.21% (Inception)
Asset Allocation
Equity
Debt
Others
Nav Movement
Investment Objective
The scheme seeks to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare.
Fund Manager
Dhimant Shah, Rohan Korde, Rajesh Bhatia
Riskometer
Very High
Top 10 Holdings
| Company | Holdings (%) |
|---|---|
| SUN PHARMACEUTICAL INDUSTRIES LTD. EQ NEW F.V. RE.1/- | 16.220000000000002 |
| DIVIS LABORATORIES LIMITED EQ NEW RS. 2/- | 5.96 |
| LUPIN LIMITED EQ NEW F.V. RS.2/- | 5.779999999999999 |
| SUVEN PHARMACEUTICALS LIMITED EQ | 5.390000000000001 |
| APOLLO HOSPITALS ENTERPRISE LIMITED EQ NEW F.V. RS.5/- | 5.16 |
| MAX HEALTHCARE INSTITUTE LIMITED EQ | 5.07 |
| TORRENT PHARMACEUTICALS LIMITED EQ NEW FV RS.5/- | 4.109999999999999 |
| AUROBINDO PHARMA LIMITED EQ NEW F.V. RE.1/- | 3.61 |
| MANKIND PHARMA LIMITED EQ NEW FV RE. 1/- | 3.09 |
| ALKEM LABORATORIES LIMITED EQ | 2.8400000000000003 |
Sector Allocation
| Sector | Holdings (%) |
|---|---|
| Healthcare | 93.58 |
| Chemicals | 4.37 |
| N/A | 2.05 |